
MLTX EPS Estimates
MoonLake Immunotherapeutics
$10.79
-$0.46(-4.09%)
43
Overall
60
Value
41
Tech
28
Quality
Market Cap
$918.30M
Volume
1.32M
52W Range
$9.46 - $23.29
Target Price
$34.93
MLTX EPS estimates: the consensus estimate for MoonLake Immunotherapeutics's current fiscal year is -$3.57 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
MLTX EPS Estimates
- EPS estimate, current quarter
- $-0.84
- EPS estimate, next quarter
- $-0.78
- EPS estimate, current year
- $-3.57
- EPS estimate, next year
- $-3.53
- EPS growth, 3-year
- -27.58%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.53 |
| 2024 | $-1.89 |
| 2023 | $-0.73 |
| 2022 | $-1.70 |
| 2021 | $-0.31 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLTX | $10.79 | -4.1% | 1.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MoonLake Immunotherapeutics Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW